首页> 外国专利> BITRANSGENIC MURINE MODEL FOR STUDYING MYELOPOIESIS, IMMUNITY AND TUMORIGENESIS

BITRANSGENIC MURINE MODEL FOR STUDYING MYELOPOIESIS, IMMUNITY AND TUMORIGENESIS

机译:用于研究骨髓细胞,免疫和透血性疾病的双基因鼠模型

摘要

A myeloid-specific c-fms-rtTA/(TetO)7-CMV-MMP12 bitransgenic mouse model was created. Induction of MMP12 abnormally elevated frequencies and numbers of common myeloid progenitor (CMP) and granulocyte/macrophage progenitor (GMP) populations, and decreased the frequency and number of the megakaryocyte/erythrocyte progenitor (MEP) population in bone marrow. CD11b+/Gr-1+ immature cell population increased in multiple organs. An immunosuppressive function on T cell proliferation and function by CD11b+/Gr-1+ immature cells was seen in vitro and in vivo from MMP12 over-expression. MMP12 stimulated (Lin) progenitor cells to differentiate into CD11b+/Gr-1+ immature cells showing immunosuppression on T cell proliferation and function in vitro. Regulatory T cells were increased. In the lung, concentration of interleukin (IL)-6 was increased, which activated oncogenic signal transducer and increased expression of Stat3 downstream genes in epithelial tumor progenitor cells. Spontaneous emphysema and lung adenocarcinoma sequentially developed after MMP12 over-expression. MMP12-induced myeloid cell autonomous defect led to abnormal myelopoiesis, immune suppression and lung adenocarcinoma.
机译:建立了骨髓特异性c-fms-rtTA /(TetO) 7 -CMV-MMP12双基因小鼠模型。 MMP12的诱导异常增加了普通骨髓祖细胞(CMP)和粒细胞/巨噬细胞祖细胞(GMP)群体的频率和数量,并降低了骨髓中巨核细胞/红细胞祖细胞(MEP)的频率和数量。 CD11b + / Gr-1 + 多器官中未成熟细胞的数量增加。从MMP12过表达的体内和体外观察到了CD11b + / Gr-1 + 未成熟细胞对T细胞增殖的免疫抑制功能。 MMP12刺激(Lin -)祖细胞分化为CD11b + / Gr-1 + 未成熟细胞,对T细胞增殖和功能具有免疫抑制作用。体外。调节性T细胞增加。在肺中,白介素(IL)-6的浓度增加,这激活了致癌信号转导子并增加了Stat3下游基因在上皮肿瘤祖细胞中的表达。 MMP12过度表达后,自然发展为自发性肺气肿和肺腺癌。 MMP12诱导的髓样细胞自主缺陷导致异常的骨髓生成,免疫抑制和肺腺癌。

著录项

  • 公开/公告号US2012204274A1

    专利类型

  • 公开/公告日2012-08-09

    原文格式PDF

  • 申请/专利权人 CONG YAN;HONG DU;

    申请/专利号US201213353272

  • 发明设计人 CONG YAN;HONG DU;

    申请日2012-01-18

  • 分类号A61K49/00;A01K67/027;

  • 国家 US

  • 入库时间 2022-08-21 17:30:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号